Vimarsana
Biggest News Aggregation in the World

Page 2 - Dirk Arnold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Arnold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Arnold Today - Breaking & Trending Today

Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board - Vimarsana News

Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board

Distinguished, world renowned experts appointed to strengthen the development of Phanes' three clinical programs in oncologySAN DIEGO, Sept. 5, 20...

Bitumen 'con men' targeting regional Australia leaving victims with shoddy work, big bills - Vimarsana News

Bitumen 'con men' targeting regional Australia leaving victims with shoddy work, big bills

Authorities say people who use the "business" are left with poor and often incomplete work — and often a sizeable invoice — before the scammers disappear into the wind.

Source: abc.net.au
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies - Vimarsana News

Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies

/PRNewswire/ -- USA News Group - English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his victory over pancreatic cancer,...

USA News Group: Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies - Vimarsana News

USA News Group: Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies

FN Media Group Presents USA News Group News Commentary VANCOUVER, British Colombia, Nov. 14, 2022 /PRNewswire/ -- USA News Group - English actor, comedian and Monty Python alumnus Eric

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort - Vimarsana News

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced updated results from the phase 1/2 GOBLET study's first-line...